insurance denied glp 1 They Cut Off My Zepbound — My GLP-1! What’s Next? LOSING GLP-1 aCCESS

The JPML found that the GLP-1 NAION lawsuits shared common questions of fact, including allegations that Plaintiffs use of certain GLP-1 RA drugs caused them to suffer from non-arteritic anterior ischemic optic neuropathy (NAION)

Both drugs use weekly injection pens

Adverse consequences of motility effects of GLP-1RAs In one study, the incidence of retained gastric contents in individuals using a GLP-1RA was 56%, compared with 19% for those not using GLP-1RAs (34), although notably there were more individuals with T2D and obesity in the group treated with GLP-1RAs

Khorram O, Laughlin GA, Yen SSC

This is most likely caused by rapid weight loss itself rather than the medication directly

Trade Policies 3.2.3.1